Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
University of South Florida
Novartis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Children's Oncology Group
University of Chicago
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
University of Rochester
Columbia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of South Florida
Case Comprehensive Cancer Center